Xtant Medical Q1 revenue up 38% to $17.9M; initiates FY2023 guidance $73-75M

Xtant Medical Holdings, Inc.

2023-Q1 EPS reported -$0.02 revenue$17,943,000

Q1 2023 revenue of $17.9M, up 38% YoY (29% organic, 9% from Coflex acquisition).
GAAP net loss improved to $2.1M ($0.02/shr) vs $2.2M ($0.03) in prior year.
Non-GAAP adjusted EBITDA loss narrowed to $0.3M from $0.9M in Q1 2022.
Full-year 2023 revenue guidance of $73M-$75M, representing 26%-29% annual growth.
Gross margin expanded to 58.7% from 58.3%, driven by Coflex contribution.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Xtant Medical Holdings, Inc. reported full year 2023 results: revenue $73 million to $75 million. Guidance initiated.

Period: full year 2023
Revenue: $73 million to $75 million
Guidance: initiated
Result: guidance update

Exact text from the filing

Xtant Medical expects full year 2023 revenue of $73 million to $75 million, representing annual growth of approximately 26% to 29% compared to full year 2022.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Xtant Medical Holdings, Inc. reported first quarter ended March 31, 2023 results: revenue $17.9 million, net income $2.1 million, or $0.02 per share, EPS $0.02 per share.

Period: first quarter ended March 31, 2023
Revenue: $17.9 million
Net income: $2.1 million, or $0.02 per share
EPS: $0.02 per share
Result: reported results

Exact text from the filing

2023 Financial Results First quarter 2023 revenue grew 38%, including organic growth of 29% and a 9% contribution from the acquisition of the Coflex and CoFix product lines, to $17.9 million, compared to $13.0 million for the same period in 2022. The increase in revenue was attributed primarily to greater independent agent sales and sales from the recently acquired

View on SEC.gov

Browse all earnings releases →

Xtant Medical Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-015373

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.